GenoFocus Balance Sheet Health
Financial Health criteria checks 3/6
GenoFocus has a total shareholder equity of ₩29.5B and total debt of ₩61.9B, which brings its debt-to-equity ratio to 210.3%. Its total assets and total liabilities are ₩97.9B and ₩68.4B respectively.
Key information
210.3%
Debt to equity ratio
₩61.93b
Debt
Interest coverage ratio | n/a |
Cash | ₩29.87b |
Equity | ₩29.45b |
Total liabilities | ₩68.41b |
Total assets | ₩97.86b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A187420's short term assets (₩43.1B) do not cover its short term liabilities (₩57.3B).
Long Term Liabilities: A187420's short term assets (₩43.1B) exceed its long term liabilities (₩11.1B).
Debt to Equity History and Analysis
Debt Level: A187420's net debt to equity ratio (108.9%) is considered high.
Reducing Debt: A187420's debt to equity ratio has increased from 9.2% to 210.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A187420 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A187420 has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 4.7% each year.